REBECCA CROWLEY-HUEY: Open Payments
NPI 1508950437 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 24 payments from 9 companies in 2025. Trend: 2023 $171 · 2024 $469 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $204 |
| Penumbra, Inc. | 1 | $168 |
| Amgen Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| Exact Sciences Corporation | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| INOGEN, INC. | 1 | $22 |
Products named: Indigo System, AIRSUPRA, OTEZLA, BREZTRI, MOUNJARO, Cologuard Collection Kit, FASENRA, Veozah.
Industry payments across NV — which companies pay providers there.
